Experimental phage therapy against Staphylococcus aureus in mice - Wikidata - awgldk - TriplyDB

Experimental phage therapy against Staphylococcus aureus in mice

Experimental phage therapy against Staphylococcus aureus in mice

http://www.wikidata.org/entity/Q24685170

about

The promise of bacteriophage therapy for Burkholderia cepacia complex respiratory infections Bacteriophages reduce experimental contamination of hard surfaces, tomato, spinach, broccoli, and ground beef by Escherichia coli O157:H7 Bacteriophages and phage-derived proteins--application approaches Importance of prophages to evolution and virulence of bacterial pathogens Methicillin-resistant Staphylococcus aureus phage plaque size enhancement using sublethal concentrations of antibiotics Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infections Strain Specific Phage Treatment for Staphylococcus aureus Infection Is Influenced by Host Immunity and Site of Infection Encapsulation of Bacteriophage in Liposome Accentuates Its Entry in to Macrophage and Shields It from Neutralizing Antibodies Application of Bacteriophage-containing Aerosol against Nosocomial Transmission of Carbapenem-Resistant Acinetobacter baumannii in an Intensive Care Unit Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.Bacteriophage-resistant Staphylococcus aureus mutant confers broad immunity against staphylococcal infection in mice.Superoxide dismutase is upregulated in Staphylococcus aureus following protoporphyrin-mediated photodynamic inactivation and does not directly influence the response to photodynamic treatment.Phage-Phagocyte Interactions and Their Implications for Phage Application as Therapeutics.Improving the safety of Staphylococcus aureus polyvalent phages by their production on a Staphylococcus xylosus strain.A method for generation phage cocktail with great therapeutic potential.Bacteriophage as effective decolonising agent for elimination of MRSA from anterior nares of BALB/c mice.Combined use of bacteriophage K and a novel bacteriophage to reduce Staphylococcus aureus biofilm formation.Detection and quantification of Flavobacterium psychrophilum-specific bacteriophages in vivo in rainbow trout upon oral administration: implications for disease control in aquaculture.Phage therapy is effective against infection by Mycobacterium ulcerans in a murine footpad model Experimental phage therapy in treating Klebsiella pneumoniae-mediated liver abscesses and bacteremia in mice T4 phage and its head surface proteins do not stimulate inflammatory mediator production Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice.Ecological basis for rational phage therapy.Experimental Phage Therapy for Burkholderia pseudomallei Infection Genome Analysis of Phage SMSAP5 as Candidate of Biocontrol for Staphylococcus aureus.Complete genome sequence of wide-host-range Staphylococcus aureus phage JD007 Learning from bacteriophages - advantages and limitations of phage and phage-encoded protein applications.SLPW: A Virulent Bacteriophage Targeting Methicillin-Resistant Staphylococcus aureus In vitro and In vivo.Bacteriophage: laboratorial diagnosis and phage therapy Microneedle-mediated transdermal bacteriophage delivery.PEGylation of bacteriophages increases blood circulation time and reduces T-helper type 1 immune response Antibody Production in Response to Staphylococcal MS-1 Phage Cocktail in Patients Undergoing Phage Therapy.Applying the ResFinder and VirulenceFinder web-services for easy identification of acquired antibiotic resistance and E. coli virulence genes in bacteriophage and prophage nucleotide sequences.Intracellular Staphylococcus aureus Control by Virulent Bacteriophages within MAC-T Bovine Mammary Epithelial Cells.M13 virus based detection of bacterial infections in living hosts.Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.Emerging drugs on methicillin-resistant Staphylococcus aureus.Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool.Use of encapsulated bacteriophages to enhance farm to fork food safety.

P2860

Q21131311-052A3243-483C-4659-81FC-BB3E4398B8D9 Q24650589-17892402-486F-4137-917B-F2696EB1CF24 Q28082731-A122F01B-0690-4AF1-BE59-4D43907E481C Q28289474-C867812C-FBCB-41F9-9A07-7AF62CEC06DB Q28390950-7D8AF637-F2EE-4BB9-B31A-1CB7AF75569C Q28394377-5BD516D9-76DC-4104-B71A-87E646E9A951 Q28546694-25CE0F58-0FC6-49BE-AC96-8F243174DDB1 Q28551599-CEE4A63B-4F3C-43D1-B634-B3662EFFEF99 Q28555082-1A8A8496-927E-4AA4-BE28-CE7748F72D4B Q28727951-D22DDDAB-FA9F-4633-A9A0-A8953B78BA9F Q33622945-A65CFDC7-DA19-4AC6-8542-759BD3FE5B07 Q33641324-2CC06CCC-C007-4DD1-9367-31DC6923781A Q33774632-7E43A026-0CB4-4C36-A3CA-3B98BDF42694 Q33850107-759BDDD0-ED26-4468-AFD3-90167B252B47 Q33952220-34C06856-6FF1-4DAE-81F0-D5EED0C04356 Q34187102-0B13266E-6B9A-48F4-A8A2-9F156E638ADB Q34538334-2FB3E5A9-44BC-4A6E-88F5-09CF1A53F6C9 Q34594381-82B6372F-389F-4D7E-BFF3-54CF174673EC Q34595583-64B7C8E6-FA1A-4745-928C-E074F4B61EE7 Q34702499-0D65EB18-7FFD-45A9-9327-419E986053D2 Q34737858-D3F94099-749D-4DB5-A9CC-99B88C3724C3 Q34970515-0DEEEAE8-521D-4B15-BB31-C10A8C9BB502 Q35296685-639CE94E-B816-4541-8757-223B0BFC97C8 Q35944299-E69A021A-D6D4-4459-ABAB-B76EF6B2A3C4 Q36069790-2151869E-CDBA-45C6-B1AD-B8E3C2FFC21C Q36380286-1448FF02-2995-425D-8A69-74FAEAE2D5BF Q36414324-BE3BE21E-A426-4183-B6FA-BAC45DA413E4 Q36676044-C3D5D421-6745-4C50-8363-BFEA5435EBF9 Q37004881-C5309B37-451A-42EA-B1A7-395C3EC07B0D Q37159339-A8064436-120A-4A78-96F5-D017B2575027 Q37187438-60CA2C3E-7FA8-457A-AD9B-ED4AE9021EA4 Q37274884-D9735CD9-AAE3-4A1B-A94F-CE7A66CE478E Q37360042-10220C57-F63E-4A4D-9A9B-B2661727941B Q37589201-B8EC322B-E42E-480B-B854-EBBEBAB9F5E8 Q37612917-BA2EC82A-257C-44A6-BF1F-ED5894F68C55 Q37707198-B7284125-A238-4BF8-9D7C-AD37FA2F9255 Q37928694-1F2ACF18-D9F2-40A6-A707-1B1529DC4822 Q38121142-65EF5B6A-CAE8-43BB-B82D-C02C3EFE38C3 Q38225652-3CF4E130-719D-452D-AF50-36C3BA1522FA Q38584325-B289CA08-DECF-4B58-87CC-69FC1FDBDC99

P2860

Experimental phage therapy against Staphylococcus aureus in mice

http://www.wikidata.org/entity/Q24685170

description

2007 nî lūn-bûn

@nan

2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Experimental phage therapy against Staphylococcus aureus in mice

@ast

Experimental phage therapy against Staphylococcus aureus in mice

@en

Experimental phage therapy against Staphylococcus aureus in mice

@nl

type

label

Experimental phage therapy against Staphylococcus aureus in mice

@ast

Experimental phage therapy against Staphylococcus aureus in mice

@en

Experimental phage therapy against Staphylococcus aureus in mice

@nl

prefLabel

Experimental phage therapy against Staphylococcus aureus in mice

@ast

Experimental phage therapy against Staphylococcus aureus in mice

@en

Experimental phage therapy against Staphylococcus aureus in mice

@nl

P1433

Q24685170-42D66444-350F-49F3-9F9B-C4B6AFA39EDE

P1476

Q24685170-1031DEB6-10D2-4D31-9796-EC5844D61957

P2093

Q24685170-538C729D-B3DB-4F37-A0B5-E8197CFA6041

Q24685170-8012FFD3-5EB6-4FDB-A772-D5641516768C

Q24685170-C66E08C0-FCCB-4998-8467-6E06D17470FF

Q24685170-EDCF16D2-88AD-40A3-AD52-A160F02E8292

Q24685170-FC9C404A-B5F4-4ACA-B603-D86A1795B765

P2860

Q24685170-099937E3-6AED-4DDE-9D60-FC98FB2FCE40

Q24685170-0B688F7B-C557-481F-B1F7-E0102B66375A

Q24685170-13400592-6119-43CF-AA5F-A39A1315EB71

Q24685170-1D62674C-69DE-4BA2-A77B-58BBB90C711E

Q24685170-205E68AF-0F01-4E07-970B-2C54C95F5C3A

Q24685170-285A4DD3-9AFE-452F-B3BF-C829FD24959F

Q24685170-340BB4AA-DB7A-4488-9A82-F931AE568CB0

Q24685170-37973847-BE30-4595-865B-08F37BA13596

Q24685170-4C348D29-271D-4010-BF4F-A0D2F6AFC1E1

Q24685170-5B76455D-5B91-44CA-B744-FB62CE12B80B

P304

Q24685170-ED4BFEF4-0003-4DF5-BDDF-07412A55045E

P31

Q24685170-54904FAF-2DF4-48C8-947E-B083C4D660C8

P3181

Q24685170-EA84A565-4E97-4DC2-ACCB-3A9F94CAFD4C

P356

Q24685170-50F89FBB-A129-4EA9-B68F-A204FBFC6518

P407

Q24685170-56F7B816-77D4-4F67-B436-F3A37A718C78

P433

Q24685170-8B5E9EDB-467D-4A22-B3C6-108F50AA06E4

P478

Q24685170-E516DD04-3EC5-417F-B360-2E543ACEB365

P577

Q24685170-5B7E7BBE-1D65-44BF-A415-B3794EFB99F4

P5875

Q24685170-97ECD93A-18D6-4988-A239-EBEBA4272C41

P698

Q24685170-58855240-07EC-4BF8-A205-041840110BA1

P932

Q24685170-89D74372-3DEF-42CC-AC0F-7BDC2270FB81

P3181

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Experimental phage therapy against Staphylococcus aureus in mice

@en

P2093

Domenico Iannelli

http://www.w3.org/2001/XMLSchema#string

Giorgia Borriello

http://www.w3.org/2001/XMLSchema#string

Marianna Parlato

http://www.w3.org/2001/XMLSchema#string

Paola Salvatore

http://www.w3.org/2001/XMLSchema#string

Rosanna Capparelli

http://www.w3.org/2001/XMLSchema#string

P2860

Bacteriophage therapy

Dynamics of success and failure in phage and antibiotic therapy in experimental infections

Staphylococcus aureus infections

Antibacterial resistance worldwide: causes, challenges and responses

Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis.

Rapid and specific detection of toxigenic Staphylococcus aureus: use of two multiplex PCR enzyme immunoassays for amplification and hybridization of staphylococcal enterotoxin genes, exfoliative toxin genes, and toxic shock syndrome toxin 1 gene.

Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance.

Multiplex PCR protocol for the diagnosis of staphylococcal infection.

In vivo efficacy of trovafloxacin against Bacteroides fragilis in mixed infection with either Escherichia coli or a vancomycin-resistant strain of Enterococcus faecium in an established-abscess murine model.

Immune evasion by staphylococci.

P304

2765-73

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

219209

http://www.w3.org/2001/XMLSchema#string

P356

10.1128/AAC.01513-06

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

51

http://www.w3.org/2001/XMLSchema#string

P577

2007-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6314513

http://www.w3.org/2001/XMLSchema#string

P698

17517843

http://www.w3.org/2001/XMLSchema#string

P932

1932491

http://www.w3.org/2001/XMLSchema#string